Digoxin, Plasma

Revision as of 12:24, 12 February 2025 by Kasey Ali Glennie (Kgl005) (talk | contribs) (Created page with "{{DISPLAYTITLE: Digoxin, Plasma}} Full Test List Biochemistry Tests {| class="wikitable" ! colspan="2" | ===''Overview''=== |- |Department |Biochemistry |- |Test Code |DIG |- |Synonyms |Digitalis  |- |Turnaround Time |1 – 5hrs  |- |Stability – Add test |8 hours |- ! colspan="2" | ===''Specimen Requirements''=== |- |Specimen Type |Serum Plasma |- |Specimen Transportation | |- |Preferred |6 mL <span style="background:#e30022"> Red-Top</span> |- |Accepta...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Tests:Digoxin, Plasma

Overview

Department Biochemistry
Test Code DIG
Synonyms Digitalis 
Turnaround Time 1 – 5hrs 
Stability – Add test 8 hours

Specimen Requirements

Specimen Type Serum

Plasma

Specimen Transportation
Preferred 6 mL Red-Top
Acceptable 6 mL Li-Hep Green-Top
Pediatric Requirements Li-Hep Microtainer

Aliquot Requirements

Sample Type Serum

Plasma

Minimum Volume 200 µL 
Aliquot Transportation

Clinical Information

Reference Intervals Range 0.6 - 2.0 nmol/L

Toxic levels >2.0 nmol/L 

Test Method Abbott Alinity Ci, Particle-enhanced turbidimetric inhibition immunoassay (PETINIA) 
Advanced Notice Not required 
Patient Preparation Samples are best taken at the trough, just before the next dose, or at least 8-12 hours post-dose, to avoid falsely high results due to delayed drug distribution after the dose. 

Comments

Specimens from patients treated with Digoxin immune FAB (Digibind) should be viewed with caution, as this substance is known to inhibit the assay.

Heterophilic antibodies have been shown to interact with immunoglobulin reagents in some immunoassay systems.